Sirolimus vs cyclosporine after induction with basiliximab does not promote regulatory T cell expansion in de novo kidney transplantation: Results from a single-center randomized trial
Carmelo Libetta(University of Pavia), Antonio Dal Canton(University of Pavia), Massimo Abelli(Policlinico San Matteo Fondazione), Elisa Margiotta(University of Pavia), Teresa Rampino(University of Pavia), Federica Meloni(University of Padua), Ilaria Borettaz(University of Pavia), Pasquale Esposito(Ospedale Policlinico San Martino), Elena Ticozzelli(Policlinico San Matteo Fondazione), Michele Canevari(University of Pavia), Marilena Gregorini(University of Pavia), Claudia Martinelli(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 15
Related Papers
Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
|International Journal of Molecular Sciences|2020|194
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy
|Journal of Nephrology|2020|82
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis
|Frontiers in Oncology|2024|74
Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
|Cancer Treatment Reviews|2023|61
GRAVITY AND TOPOGRAPHY
|Mars|2018|40